Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 17 Sept 2026 for Arcutis Biotherapeutics, Inc., €4,645. Read the official filing
Filing timeline
BuySaleHoward G. Welgus
Insider track record
Disclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Howard G. Welgus: trading record in brief
Howard G. Welgus is a declared insider of Arcutis Biotherapeutics, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 3 May 2021 to 15 September 2026, the count stands at 70 filings.
On the market, this insider has only sold: 29 sales, €3.7M in total. No amount is published for 2 filings, which the totals therefore leave out. Outside the open market, there are 5 share grants and 36 option exercises. So far in 2026, the count stands at no purchases and 10 sales.
The newest entry dates from 17 September 2026: an option exercise of €6,630, in Arcutis Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Howard G. Welgus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations70 total
822 shares@ US$6.5223Common StockSEC:0001628280-26-062490:0
1,019 shares@ US$7.51Common StockSEC:0001628280-26-062490:1
2,255 shares@ US$8.63Common StockSEC:0001628280-26-062490:2
4,730 shares@ US$24.18Common StockSEC:0001628280-26-062490:3
822 shares@ US$6.52230.0002% mcap0.1% of flowCommon StockSEC:0001628280-26-058008:0
1,019 shares@ US$7.510.0002% mcap0.2% of flowCommon StockSEC:0001628280-26-058008:1
2,255 shares@ US$8.630.0006% mcap0.4% of flowCommon StockSEC:0001628280-26-058008:2
4,730 shares@ US$26.18070.0037% mcap2.8% of flowCommon StockSEC:0001628280-26-058008:3
1,019 shares@ US$7.510.0002% mcap0.2% of flowCommon StockSEC:0001628280-26-048641:1
822 shares@ US$6.52230.0002% mcap0.1% of flowCommon StockSEC:0001628280-26-048641:0
4,730 shares@ US$26.910.0037% mcap3.0% of flowCommon StockSEC:0001628280-26-048641:3
2,255 shares@ US$8.630.0006% mcap0.5% of flowCommon StockSEC:0001628280-26-048641:2
822 sharesCommon StockSEC:0001628280-26-044079:0
1,019 sharesCommon StockSEC:0001628280-26-044079:1
2,255 sharesCommon StockSEC:0001628280-26-044079:2
4,096 sharesCommon StockSEC:0001628280-26-044079:3
635 sharesCommon StockSEC:0001628280-26-044079:4
5,778 shares0Common StockSEC:0001628280-26-042044:0
7,144 shares@ US$22.98710.0053% mcap8.4% of flowCommon StockSEC:0001801050-26-000002:0
10,000 shares@ US$23.88010.0077% mcap12.4% of flowCommon StockSEC:0001628280-26-023736:0
10,000 shares@ US$25.65186.2% of flowCommon StockSEC:0001628280-26-014639:0
10,000 shares@ US$25.04830.0079% mcap12.7% of flowCommon StockSEC:0001628280-26-005567:0
10,000 shares@ US$28.96060.0092% mcap14.9% of flowCommon StockSEC:0001628280-26-000969:0
10,000 shares@ US$30.21337.9% of flowCommon StockSEC:0001801050-25-000008:0
10,000 shares@ US$25.26697.2% of flowCommon StockSEC:0001801050-25-000007:0
25 of 70 declarations
